Erlotib 150 mg Tablet
33.71$
26.29$
Erlotib 150 mg Tablet is a targeted therapy specifically designed to combat certain cancers, including non-small cell lung cancer (NSCLC) and pancreatic cancer. This medication works by inhibiting the activity of epidermal growth factor receptor (EGFR) tyrosine kinase, which plays a crucial role in cancer cell growth and survival. By blocking this pathway, Erlotib helps to slow down or stop the proliferation of cancerous cells, potentially leading to improved outcomes for patients. It's important to note that while Erlotib is effective, it may also cause side effects such as skin rash, diarrhea, and fatigue, which should be monitored closely. Patients are advised to undergo regular check-ups to assess their response to treatment and manage any adverse effects promptly. As with any cancer treatment, discussing potential interactions with other medications and existing health conditions with your healthcare provider is essential for safe use. By understanding its function and risks, patients can make informed decisions about incorporating Erlotib into their cancer treatment plan.
الكمية
Active Pharmaceutical Ingredient
Uses
• Erlotib 150 mg tablet is primarily used for the treatment of non-small cell lung cancer. This form of lung cancer can lead to symptoms such as persistent cough, chest pain, and shortness of breath. By targeting specific pathways in cancer cells, Erlotib 150 mg tablet helps to slow down the progression of the disease. Patients may experience an improvement in their quality of life as the treatment works to manage symptoms.
• In the context of pancreatic cancer, Erlotib 150 mg tablet is often prescribed alongside gemcitabine. This combination therapy aims to enhance the effectiveness of treatment against pancreatic tumors. Patients may experience various symptoms, including abdominal pain and weight loss, which can be alleviated as the cancer is managed. The use of Erlotib 150 mg tablet in this setting provides a targeted approach to combatting the disease.
• Erlotib 150 mg tablet is also beneficial for patients who have previously received chemotherapy or radiation therapy. It can be an effective option for those who need further treatment to control their cancer. This medication works by inhibiting tumor growth and may contribute to better outcomes in managing cancer progression. Many patients find Erlotib 150 mg tablet to be a valuable addition to their cancer treatment plan.
• The use of Erlotib 150 mg tablet extends to patients with specific genetic markers associated with non-small cell lung cancer. Testing for these markers can determine the suitability of Erlotib 150 mg tablet for individual patients. By personalizing cancer treatment based on genetic information, healthcare providers aim to improve treatment efficacy. This tailored approach is becoming increasingly important in oncology.
Benefits
Erlotib Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Anti-cancer Drug Erlotib can help to slow the progression of cancer. Erlotib 150 mg Pack may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Erlotib 150 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Erlotib 150 mg Pack can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Diarrhea
• Vomiting
• Gas
• Heartburn
• Mouth sores
• Constipation
• Headache
• Weight Loss
• Muscle or bone pain
• Anxiety
• Depression
• Hair loss
• Swelling of hands, feet, arms, lower legs or ankles
• Changes in nail and hair appearance
Common Side Effects
• Sudden chest pain
• Severe stomach pain
• Vision problems
• Heart attack
• Stroke
• Kidney or liver problems
• Rash
• Cough
• Peeling, blistering, cracked or dry skin
• Itching
• Tenderness
• Burning of the skin
• Fever
• Ingrown eyelash
• Pain in the neck, upper back or arms
• Difficult or slow speech
• Dizziness
• Weakness
• Dry mouth
• Dark urine
• Yellow or pale skin
How To Use
Take this medicine on an empty stomach, one hour before food or two hours after food. It is best to take exactly as prescribed by your doctor. Do not take more or less than directed. If you have trouble swallowing the Erlotib 150 mg, you may crush the tablets and mix the powder with a small amount of water. Drink the mixture immediately. You should take the Erlotib 150 mg Tablet at the same time each day to help you remember to take it. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. Do not stop taking the Erlotinib Tablet 150 mg without first consulting your doctor.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Erlotib 150 mg Pack. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Erlotib 150 mg Pack is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Erlotib 150 mg Tablet is recommended. The use of Erlotib 150 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Erlotib Tablet. Erlotib 150 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Erlotib 150 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Erlotib Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Erlotib 150 mg Tablet is recommended. The use of Erlotinib Tablet 150 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Erlotinib Tablet 150 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erlotib 150 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Anti-cancer Drug Erlotib is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Erlotib 150 mg Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved